key: cord-0852521-t6ap6w9h authors: Pennarossa, Georgia; Fazeli, Alireza; Ledda, Sergio; Gandolfi, Fulvio; Brevini, Tiziana A. L. title: Use of Virus-Mimicking Nanoparticles to Investigate Early Infection Events in Upper Airway 3D Models date: 2021-02-19 journal: Next Generation Culture Platforms for Reliable In Vitro Models DOI: 10.1007/978-1-0716-1246-0_8 sha: 727d1421b3e79e747008a8013cbd7ab5e62445c5 doc_id: 852521 cord_uid: t6ap6w9h The current coronavirus disease-19 (COVID-19) pandemic, caused by “severe acute respiratory syndrome coronavirus 2” (SARS-CoV-2), underscores the threat posed by newly emerging viruses. The understanding of the mechanisms driving early infection events, that are crucial for the exponential spread of the disease, is mandatory and can be significantly implemented generating 3D in vitro models as experimental platforms to investigate the infection substrates and how the virus invades and ravages the tissues. We here describe a protocol for the creation of a synthetic hydrogel-based 3D culture system that mimics in vitro the complex architectures and mechanical cues distinctive of the upper airway epithelia. We then expose the in vitro generated 3D nasal and tracheal epithelia to gold nanoparticles (AuNPs) that display the typical shape and size distinctive of SARS-CoV-2 and of the majority of Coronaviridae presently known. The infection platform here described provides an efficient and highly physiological in vitro model that reproduces the host–pathogen early interactions, using virus-mimicking nanoparticles, and offers a flexible tool to study virus entry into the cell. At the same time, it reduces the risk of accidental infection/spillovers for researchers, which represents a crucial aspect when dealing with a virus that is highly contagious, virulent, and even deadly. The current coronavirus outbreak caused by "severe acute respiratory syndrome coronavirus 2" (SARS-CoV-2) is the gravest health crisis the World has seen in a century, with an unprecedent death toll and number of patients in urgent need of hospital treatment [1] . According to the World Health Organization, the situation report update at 08 July 2020 is 11,635,939 of total confirmed cases and 539,026 the deaths, with the USA and Europe as epicenters of the global pandemic, and 6,004,685 and 2,809,848 confirmed cases respectively [2] . Although, SARS-CoV-2 has a relatively low/medium mortality rate, it is highly contagious, leading to an explosive and exponential spread of the infection [3] . The understanding of the first events controlling the mechanisms that lead to the rapid spread of the disease are therefore crucial for its containment and the early detection [4] . Typical in vitro experiments carried out by virologists use cell lines cultured into 2D culture systems [5] , that are only poorly resemble real tissue behavior, especially in terms of structural and functional proprieties, nor its interactions with SARS-CoV-2. 3D in vitro models have been currently developed to better investigated the in vivo infection substrates and allow for studying how the new coronavirus invades and ravages the body. We here describe a protocol for the generation of reliable 3D in vitro models of upper respiratory tract, namely, nose and trachea. We propose the use of a synthetic hydrogel-based 3D culture system that is able to reproduce in vitro the complex biochemical and mechanical cues deriving from the native extracellular matrix [6, 7] as well as several aspects of the native cellular microenvironment, mimicking the original conditions of the airway epithelia [8] . To stimulate the mechanisms active at early stages of infection-prior to viral replication-and allows to study how the virus interacts and invades cells of the upper respiratory tract, we implement a nanomedicine-based approach, exposing the 3D in vitro generated nasal and tracheal epithelia to gold nanoparticles (AuNPs) (Fig. 1 ). In particular, we select AuNPs spherical in shape and with size ranging from 60 to 140 nm, which are distinctive features of SARS-CoV-2 and common to the majority of Coronaviridae presently known [9] [10] . In addition, in order to address the different mechanisms used by Coronaviridae to enter cells, the same protocol can be applied using nanoparticles with surface ad hoc activated or caged with coronavirus envelope spike proteins [11, 12] . Overall, the bioengineered model of infection here described provides an efficient and highly physiological in vitro platform that mimics the host-pathogen early interaction and offers a powerful insight on the possible strategies to prevent virus entry into the cell (Fig. 2 ). In addition, beside its predictive power and flexibility, it also ensures safety. This latter represents a crucial aspect, since dealing with a virus that is highly contagious, virulent and even deadly, inevitably reduces the manpower and the number of laboratories that have high protection facilities, significantly affecting in a way the intellectual and scientific resources to fight this as well as other future pandemics. Finally, the 3D cell-based assay here proposed could contribute to reduce the use of experimental animal studies, the uncertainties arising from monolayer cultures and hence the cost of subsequent screening processes. Prepare all solutions immediately before use (unless indicated otherwise). 3 Methods All the procedures described below must be performed under sterile conditions. Cell manipulation must be carried out under laminar flow hood and cell cultures have to be maintained at 37 C during their handling using thermostatically controlled stages. 2. Immerse hydrogels in EC culture medium and incubate at room temperature for a minimum of 30 min. 3. Trypsinize cells (see Subheading 3.1, steps 3-6). 4. Collect cell suspension and transfer it in a 15 mL centrifuge polystyrene tube. 5. Count cells using a counting chamber under an optical microscope at room temperature. Calculate the volume of medium needed to resuspend cells in order to obtain a concentration of 6.5  10 4 cells/cm 2 (see Note 7). 6. Centrifuge at 300  g for 5 min. 7. Remove supernatant carefully and resuspend the cell pellet in the previously calculated volume (see step 3) of EC culture medium by pipetting. 8. Plate cells onto hydrogels. 9. Transfer into CO 2 incubator. 10 . Incubated overnight for cell attachment. Prepare PVP-AuNP solution by diluting PVP-AuNPs to 70μg/mL in EC culture medium (see Note 8) Mix solution by gently pipetting three times Carefully aspirate the culture medium for culture dish Wash cells three times with PBS supplemented with 1% antibiotic-antimycotic solution Add of PVP-AuNPs solution to cells Epidemiology of fatal cases associated with pandemic H1N1 influenza WHO Coronavirus Disease (COVID-19) Dashboard|WHO Coronavirus Disease (COVID-19) Dashboard Joining European Scientific Forces to Face Pandemics Trends in Microbiology Role of cell culture for virus detection in the age of technology Epigenetic erasing and pancreatic differentiation of dermal fibroblasts into insulinproducing cells are boosted by the use of low-stiffness substrate Extracellular matrix-based materials for regenerative medicine Choosing the right differentiation medium to develop Mucociliary phenotype of primary nasal epithelial cells in vitro A novel Coronavirus from patients with pneumonia in China Clinical cancer nanomedicine Insights from nanomedicine into chloroquine efficacy against COVID-19 The pivotal link between ACE2 deficiency and SARS-CoV-2 infection This work was funded by Carraresi Foundation. Authors are member of the COST Action CA16119 In vitro 3-D total cell guidance and fitness (CellFit) and of the Inter-COST Actions Task-Force on Covid-19. 7. At the end of the desired culture period, wash cells twice with PBS and analyze PVP-AuNPs absorption of by transmission electron microscopy. 1. Hydrogels must be stored at 4 C and used within 6 months of the printed manufacture date.2. PVP-AuNPs must be stored at 4 C. As an alternative AuNPs can be replaced with polyvinylpyrrolidone coated silver NPs, which, however, must be protected from light, beside storing at 4 C.3. Confluency normally takes between 7 and 10 days. If cells are not confluent after 10 days, they are not successfully growing.4. The trypsin volume here reported is necessary for detaching cell cultured in a T25 flask. When working with bigger dish, scale up the volumes accordingly.5. It usually takes 2-3 min.6. The recommended seeding density is 10,000-15,000 cells per cm 2 .7. The formula to be used depends on the specific type of chamber. Cells/μL ¼ Average number of cells per small grid  chamber multiplication factor  dilution.8. PVP-AuNPs tend to rapidly cluster, prepare PVP-AuNP solution immediately prior to the use.